Richard William Scalzo, CFO: Crescent Biopharma CBIO Sell · Filed 06/23

Trade details

Type: Insider sale
Amount: $20,004.88
Shares · price: 1,112 sh · $17.99 a share
Held after: 20,298 sh
Stock: Crescent Biopharma CBIO
Person: Richard William ScalzoCFO
Trade date: 26/06/22
Filed: 26/06/23
Days to filing: 1 days

Sold 5.2% of holdings

Share of holding sold: 5.2%

Crescent Biopharma trades, last 26 weeks

What else happened in Crescent Biopharma around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Richard William Scalzo's recent trades

Richard William ScalzoOfficer
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$19.6K
1,330 sh
$19.6K
Filed 25/06/11
Traded 25/06/11
Richard William ScalzoOfficer
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$12.2K
914 sh
$12.2K
Filed 25/06/05
Traded 25/06/05
Richard William ScalzoOfficer
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$29.3K
2,479 sh
$29.3K
Filed 25/05/16
Traded 25/05/16
Richard William ScalzoSVP, Head of Finance & Admin
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$15.3K
1,343 sh
$15.3K
Filed 25/03/13
Traded 25/03/11
Richard William ScalzoSEE REMARKS
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$15.3K
1,343 sh
$15.3K
Filed 25/03/11
Traded 25/03/11